Adamas Pharmaceuticals - PharmaKB

Company Reports

Company Reports

Disease Reports

Disease Reports

Company ReportsAdamas Pharmaceuticals

Adamas Pharmaceuticals(ADMS)

Download report

Favorite

Financial

Marketed Drugs

Clinical Trials

Financial

Stock price

*Currency in USD

Company Revenue

Quarterly

Quarterly

Annual

Annual

Projections

*Quarterly sales USD (in millions)

Plot placeholder

Mock data
Subscribe for the real data

Revenue by Drug

Marketed Drugs

No data

Clinical Trials

Therapeutic Areas:

All

Classification:

All

Approval:

All

Status:

All

Phases:

All

Drug Name

Phase 1

Phase 2

Phase 3

Phase 4

Indication

Microcrystalline cellulose

,

muscular atrophy

,

,

,

colorectal neoplasms

,

,

chronic obstructive pulmonary disease

,

ulcerative colitis

,

,

,

respiratory tract diseases

,

respiration disorders

,

multiple sclerosis

,

relapsing-remitting multiple sclerosis

,

,

,

healthy volunteers/patients

,

,

,

hiv-associated lipodystrophy syndrome

,

,

human influenza

,

,

falciparum malaria

,

,

,

multiple myeloma

,

plasma cell neoplasms

,

,

graves ophthalmopathy

,

,

rheumatoid arthritis

,

,

,

neisseria meningitidis

,

haemophilus infections

,

,

b-cell chronic lymphocytic leukemia

,

lymphoid leukemia

,

non-hodgkin lymphoma

,

prehypertension

,

type 2 diabetes mellitus

,

,

diabetes mellitus

,

,

acquired immunodeficiency syndrome

,

immunologic deficiency syndromes

,

,

,

,

,

haemophilus influenzae type b

,

,

renal insufficiency

,

,

,

,

,

,

communicable diseases

,

,

dental focal infection

,

focal infection

,

chronic hepatitis b

,

,

chronic hepatitis

,

,

facial paralysis

,

,

thrombocytopenic purpura idiopathic

,

thrombocytopenic purpura

,

,

immunologic tests

,

clostridioides difficile

,

chronic obstructive pulmonary disease

,

pneumococcal pneumonia

,

haemophilus influenzae

,

streptococcus pneumoniae

,

,

respiratory tract diseases

,

respiration disorders

,

,

neisseria meningitidis

,

,

respiratory syncytial virus infections

,

influenza in birds

,

,

,

,

,

,

,

,

,

meningococcal infections

,

human influenza

,

h1n1 subtype influenza a virus

,

haemophilus influenzae type b

,

,

,

healthy volunteers/patients

,

,

,

respiratory tract infections

,

communicable diseases

,

disease progression

,

,

,

,

bronchial spasm

,

multiple sclerosis

,

,

,

,

,

infectious encephalitis

,

immunologic tests

,

,

,

pneumococcal infections

,

,

,

drug-related side effects and adverse reactions

,

chronic obstructive pulmonary disease

,

pneumococcal pneumonia

,

haemophilus influenzae

,

streptococcus pneumoniae

,

,

respiratory tract diseases

,

respiration disorders

,

,

neisseria meningitidis

,

,

respiratory syncytial virus infections

,

influenza in birds

,

,

,

,

,

,

,

,

,

meningococcal infections

,

human influenza

,

h1n1 subtype influenza a virus

,

haemophilus influenzae type b

,

,

,

healthy volunteers/patients

,

,

,

respiratory tract infections

,

communicable diseases

,

disease progression

,

,

,

,

bronchial spasm

,

multiple sclerosis

,

,

,

,

,

infectious encephalitis

,

immunologic tests

,

,

,

pneumococcal infections

,

,

,

drug-related side effects and adverse reactions

,

chronic obstructive pulmonary disease

,

pneumococcal pneumonia

,

haemophilus influenzae

,

streptococcus pneumoniae

,

,

respiratory tract diseases

,

respiration disorders

,

,

neisseria meningitidis

,

,

respiratory syncytial virus infections

,

influenza in birds

,

,

,

,

,

,

,

,

,

meningococcal infections

,

human influenza

,

h1n1 subtype influenza a virus

,

haemophilus influenzae type b

,

,

,

healthy volunteers/patients

,

,

,

respiratory tract infections

,

communicable diseases

,

disease progression

,

,

,

,

bronchial spasm

,

multiple sclerosis

,

,

,

,

,

infectious encephalitis

,

immunologic tests

,

,

,

pneumococcal infections

,

,

,

drug-related side effects and adverse reactions

© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use